Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Mario Fernández-Ruiz and Octavio Carretero.
Mario Fernández-Ruiz
Connection Strength
0.470
Octavio Carretero
  1. Tocilizumab therapy in SARS-CoV-2 pneumonia: A matched retrospective cohort analysis. Med Clin (Barc). 2021 Jun 18.
    View in: PubMed
    Score: 0.238
  2. IL-6-based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts. J Allergy Clin Immunol. 2021 05; 147(5):1652-1661.e1.
    View in: PubMed
    Score: 0.058
  3. Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study. Int J Infect Dis. 2021 Apr; 105:487-494.
    View in: PubMed
    Score: 0.058
  4. Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study. Int J Infect Dis. 2021 Apr; 105:319-325.
    View in: PubMed
    Score: 0.058
  5. Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021 Jun; 40(6):1209-1216.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.